A new engineered gene-editing system, proven in bacteria and showing promise for use in plants, animals and humans, addresses ...

Caribou Biosciences is stopping work on its two remaining cancer cell therapies and exploring strategic alternatives for the ...

The Berkeley gene-editing company will wind down its lymphoma and myeloma studies and explore a potential sale.

Despite having an allogeneic cell therapy prospect that’s ready for late-stage testing in lymphoma, Caribou couldn’t secure ...

Ingredalia has won a FoodTech Emprende Award in Barcelona. The Navarra startup received the prize for its bioactive ...

Fintel reports that on 6 October 2026, Barclays initiated coverage of Intellia Therapeutics (DB:38I) with a Underweight recommendation. This initiation of coverage by Barclays follows a prior action ...

President Trump will present the National Medal of Science and National Medal of Technology and Innovation to prominent tech CEOs including Elon Musk Satya Nadella and Michael Dell.These awards ...

If you have a social media account, you’ve almost certainly seen plenty of stories about scientific discoveries that are set ...

India can become a science-driven, globally impactful nation by liberating labs, expanding education, and streamlining regulation.

A quarter-century ago, genetic modification stood as one of the most contentious political and environmental issues in New ...

Ginkgo Bioworks (DNA.N) is currently riding a strong technical wave, with the stock price up 44.64% in the recent period, ...